GemPharmatech (688046.SH) shareholder Qingdao National Pharmaceutical reduced its holdings by 888,200 shares, decreasing its stake to 5%.
Yaokang Biopharmaceuticals (688046.SH) announced that on September 24, 2024, the company's shareholder, Qingdao Guoyao Daichuang...
GemPharmatech (688046.SH) announced on September 24, 2024, that its shareholder Qingdao Guoyao DaChuang Investment Partnership Enterprise (Limited Partnership) (referred to as "Qingdao Guoyao") has reduced its shareholding in the company by 888,200 shares through block trading, accounting for 0.22% of the total share capital of the company. After this equity change, Qingdao Guoyao holds a reduced stake of 5% in the company.
Related Articles
EVERG VEHICLE (00708) Announces 2025 Annual Results: Loss Attributable to Shareholders of RMB 891 Million, Turning from Profit to Loss Year-on-Year
EVERG VEHICLE (00708) Announces 2025 Interim Results: Loss Attributable to Shareholders of RMB 585 Million, a Year-on-Year Decrease of 97.11%
Sinolink: Accelerated supply clearance in photovoltaic glass; leading players' profit recovery and share rebound highly certain.
EVERG VEHICLE (00708) Announces 2025 Annual Results: Loss Attributable to Shareholders of RMB 891 Million, Turning from Profit to Loss Year-on-Year
EVERG VEHICLE (00708) Announces 2025 Interim Results: Loss Attributable to Shareholders of RMB 585 Million, a Year-on-Year Decrease of 97.11%
Sinolink: Accelerated supply clearance in photovoltaic glass; leading players' profit recovery and share rebound highly certain.
RECOMMEND
